---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-24-000052"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:39:56.141454+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Moderna appoints Abbas Hussain, ex-CEO of Vifor Pharma, to Board of Directors

## Summary
- Hussain appointed effective Oct 2, 2024; board size fixed at nine directors.
- He brings over 35 years of healthcare leadership, including former CEO of Vifor Pharma and Global President of GSK Pharmaceuticals & Vaccines.
- Hussain will serve on the Audit Committee and receive standard non-employee director compensation plus initial and pro-rata annual equity grants.
- No arrangements or relationships requiring disclosure under Item 404(a) of Regulation S-K.

## SEC filing metadata
- accession: 0001682852-24-000052
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/0001682852-24-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/mrna-20240928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-24-000052
- JSON: https://secwatch.observer/filing/0001682852-24-000052.json
- Plain text: https://secwatch.observer/filing/0001682852-24-000052.txt

## Key facts
- Executive change
  Abbas Hussain was appointed as Director at Moderna, Inc..
  - Action: appointed
  - Role: Director
  source text: On September 28, 2024, the Board of Directors (the “Board”) of Moderna, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Abbas Hussain to the Board, effective October 2, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/0001682852-24-000052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.